Skip to main content
SpringerLink
Log in

New strategies for prevention of ischemic stroke: The life study

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

New strategies to lower the risk of stroke among highrisk persons are being developed. Therapies such as cholesterol-lowering medications and newer antihypertensive agents appear to complement traditional antithrombotic drugs and surgical procedures. Of particular interest is the use of the newer angiotensin-converting enzyme (ACE) inhibitors, which appear to have an effect on stabilizing the vascular endothelium. The Losartan Intervention For Endpoint (LIFE) reduction in hypertension study provides additional data to support the use of the ACE inhibitors to lower the risk of stroke among patients with hypertension and vascular diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Antithrombotic Trialist’s Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324:71–86.

    Article  Google Scholar 

  2. Blauw GJ, Lagaay AM, Smelt AH, Westendorp RG: Stroke, statins, and cholesterol. Stroke 1997, 28:946–950.

    PubMed  CAS  Google Scholar 

  3. Byington RP, Jukema JW, Salonen JT, et al.: Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. Circulation 1995, 922:2419–2425.

    Google Scholar 

  4. Hebert PR, Gaziano JM, Chan KS, Hennekens CH: Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA 1997, 278:313–321.

    Article  PubMed  CAS  Google Scholar 

  5. Crouse JR, Byington RP, Furberg CD: HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data. Atherosclerosis 1998, 138:11–24.

    Article  PubMed  CAS  Google Scholar 

  6. Yusuf S, Sleight P, Pogue J, et al.: Effects of an angiotensinconverting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000, 342:145–153.

    Article  PubMed  CAS  Google Scholar 

  7. PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure lowering regimen among 6,105 individuals with previous stroke or transient ischemic attack. Lancet 2001, 358:1026–1027.

    Article  Google Scholar 

  8. Neal B, MacMahon S, Chapman N: Blood Pressure Lowering Treatment Trialist’s Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000, 356:1955–1964.

    Article  PubMed  CAS  Google Scholar 

  9. Dahlöf B, Devereux RB, Kjeldsen SE, et al., for the LIFE Study Group: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002, 359:995–1003. Important study.

    Article  PubMed  Google Scholar 

  10. Lindholm LH, Ibsen H, Dahlöf B, et al., for the LIFE Study Group: Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002, 359:1004–1010. Important study.

    Article  PubMed  CAS  Google Scholar 

  11. Sacco RL: Risk factors and outcomes for ischemic stroke. Neurology 1995, 45:S10-S14.

    PubMed  CAS  Google Scholar 

  12. Lindenstrom E, Boysen G, Nyboe J: Influence of systolic and diastolic blood pressure on stroke risk: a prospective observational study. Am J Epidemiol 1995, 142:1279–1290.

    PubMed  CAS  Google Scholar 

  13. MacMahon S, Peto R, Cutler J, et al.: Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1992, 335:765–774.

    Article  Google Scholar 

  14. Phillips SJ, Whisnant JP: Hypertension and the brain. The National High Blood Pressure Education Program. Arch Intern Med 1992, 152:938–945.

    Article  PubMed  CAS  Google Scholar 

  15. Staessen JA, Thijs L, Gasowski J, Cells H, Fagard RH: Treatment of isolated systolic hypertension in the elderly: further evidence from the systolic hypertension in TEurope (Syst-Eur) trial. Am J Cardiol 1998, 82:20R-22R.

    Article  PubMed  CAS  Google Scholar 

  16. Hansson L: The Hypertension Optimal Treatment Study and the importance of lowering blood pressure. J Hypertens 1999, 17(suppl):S9–13.

    Article  CAS  Google Scholar 

  17. Kannel WB: Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996, 275:1571–1576.

    Article  PubMed  CAS  Google Scholar 

  18. Klungel OH, Stricker BH, Paes AH, et al.: Excess stroke among hypertensive men and women attributable to undertreatment of hypertension. Stroke 1999, 30:1312–1318.

    PubMed  CAS  Google Scholar 

  19. Hansson L, Hedner T, Lund-Johansen P, et al.: Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Lancet 2000, 356:359–365.

    Article  PubMed  CAS  Google Scholar 

  20. Dzau VJ, Bernstein K, Celermajer D, et al., for the Working Group on Tissue Angiotensin-converting enzyme, International Society of Cardiovascular Pharmacotherapy: The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am J Cardiol 2001, 88:1L-20L.

    Article  PubMed  CAS  Google Scholar 

  21. Bakris GL: Angiotensin-converting enzyme inhibition to enhance vascular health-clinical and research models. Am J Hypertens 2002, 14:264S-269S.

    Article  Google Scholar 

  22. Islim IF, Bareford D, Beevers DG: A single (investigator)-blind randomised control trial comparing the effects of quinapril and mifedipine on platelet function in patients with mild to moderate hypertension. Platelets 2001, 12:274–278.

    Article  PubMed  CAS  Google Scholar 

  23. Calles-Escandon J, Cipolla M: Diabetes and endothelial dysfunction: a clinical perspective. Endocrine Rev 2001, 22:36–52.

    Article  CAS  Google Scholar 

  24. Myers BD, Boothroyd D, Olshen RA: Angiotensin-converting enzyme inhibitor for slowing progression of diabetic and nondiabetic kidney disease. J Am Soc Nephrol 1998, 9:S66-S70.

    PubMed  CAS  Google Scholar 

  25. Borghi C, Ambrosioni E: Evidence-based medicine and ACE inhibition. J Cardiovasc Pharmacol 1998, 32:S24-S35.

    PubMed  CAS  Google Scholar 

  26. Lazar HL, Bao Y, Rivers S, Colton T, Bernard SA: High tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size. Ann Thoracic Surg 2001, 72:548–553.

    Article  CAS  Google Scholar 

  27. Taddei S, Virdis A, Ghiadoni L, Mattei P, Salvetti A: Effects of angiotensin converting enzyme inhibition on endotheliumdependent vasodilatation in essential hypertensive patients. J Hypertens 1998, 16:447–456.

    Article  PubMed  CAS  Google Scholar 

  28. Enseleit F, Hurlimann D, Luscher TF: Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events. J Cardiovasc Pharmacol 2001, 37:S21-S30.

    PubMed  CAS  Google Scholar 

  29. Niskanen L, Hedner T, Hansson L, Lanke J, Niklason A, for the The CAPPP Study Group. Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/ beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project. Diabetes Care 2001, 24:2091–2096.

    Article  PubMed  CAS  Google Scholar 

  30. Gorelick PB: Stroke prevention therapy beyond antithrombotics. Unifying mechanisms in ischemic stroke pathogenesis and implications for therapy. Stroke 2002, 33:862–875.

    Article  PubMed  Google Scholar 

  31. Alberts MJ: Secondary prevention of stroke and the expanding role of the neurologist. Cerebrovasc Dis 2002, 13(suppl 1):12–16.

    Article  PubMed  CAS  Google Scholar 

  32. Hess DC, Demchuk AM, Brass LM, Yatsu FM: HMG-CoA reductase inhibitors (statins). A promising approach to stroke prevention. Neurology 2000, 54:790–796.

    PubMed  CAS  Google Scholar 

  33. Pyorala M, Miettinen H, Halonen P, Laakso M, Pyorala K: Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol 2000, 20:538–544.

    PubMed  CAS  Google Scholar 

  34. Sakkinen PA, Wahl P, Cushman M, Lewis MR, Tracy RP: Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 2000, 152:897–907.

    Article  PubMed  CAS  Google Scholar 

  35. Pihlajamaki J, Austin M, Edwards K, Laakso M: A major gene effect on fasting insulin and insulin sensitivity in familial combined hyperlipidemia. Diabetes 2001, 50:2396–2401.

    Article  PubMed  CAS  Google Scholar 

  36. Hevener AL, Reichart D, Janez A, Olefsky J: Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats. Diabetes 2001, 50:2316–2322.

    Article  PubMed  CAS  Google Scholar 

  37. Smith U: Pioglitazone: mechanism of action. Int J Clin Pract 2001, 121(suppl):13–18.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Iowa, 200 Hawkins Drive, 52246, Iowa City, IA, USA

    Harold P. Adams Jr. MD

Authors
  1. Harold P. Adams Jr. MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adams, H.P. New strategies for prevention of ischemic stroke: The life study. Curr Neurol Neurosci Rep 3, 46–51 (2003). https://doi.org/10.1007/s11910-003-0036-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-003-0036-7

Keywords

Search

Navigation